In as little as a few minutes, the SphenoCath® device and procedure for administering a sphenopalatine ganglion (SPG) block provides most patients with immediate relief of headache pain.
In as little as a few minutes, the newSphenoCath® device and procedure for administering a sphenopalatine ganglion (SPG) block provides most patients with immediate relief of headache pain with a simple, gentle, comfortable in-office procedure. The revolutionarySphenoCath® device delivers anesthetic through the nasal cavity, effectively delivering an SPG block for migraine pain without the use of needles, cotton swabs, or harsh meds. For most, the procedure is comfortable, while others may briefly feel a very slight nasal irritation. This device allows a low risk, simple procedure that is a pain management game-changer for anyone who experiences four or more severe headaches a year.
The SphenoCath is composed of a semi-rigid ticothane, and tico-tungsten sheath (gray) with an inner, pliable catheter and hub (purple—shown extended, above).
The SphenoCath is a registered FDA
Catagory-1 trans nasal drug delivery
The SphenoCath is specifically designed
to facilitate the delivery of local
anesthetic to the para-sympathetic,
sympathetic, and V2 maxillary divisions
of the head’s principle autonomic
The SphenoCath allows SIMULTANEOUS
drug delivery access to the bilateral
Sphenopalitine Ganglia (SPG), V2, and
associated fibers involved with the
entire SPG circuit: A feat not achievable
with trans-nasal pledget (Q-tip), or
infrazygomatic long needle approach,
With the patient in supine position, the device is inserted into the nasal cavity until reaching the superior aspect of nasal bone.(catheter not yet extended).
The device is then withdrawn 1 cm
The inner catheter is extended and the local anesthetic is delivered. The procedure is repeated in the other nostril, and the patient remains in place for 7-10 minutes to maximize mucosal absorption.
Benefits of using the SphenoCath®device in an SPG/PPG Block Procedure:
2 to 5 minute in-office procedure
Majority of patients experience immediate relief
Very low risk
Very high success rates
Safe for adults and children
Reimbursed by most insurance companies & Medicare
Increases new-patient and repeat traffic
Safety and Efficacy
Careful tracking of procedural endeavors throughout the US and beyond, demonstrates exceptional patient tolerance, and no reported severe adverse events or reactions.
Some patients may notice a metallic taste from the Lidocaine during the procedure.
Some patients may experience slight perceived difficulty swallowing, during the procedure, due to SENSORY numbness in the throat. (Verbal reassurance will usually suffice, but a sip of liquid with flexible straw, so that patient positioning is uninterrupted is fine.)